Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Andrea Ambrosini-Spaltro"'
Autor:
Andrea Ambrosini-Spaltro, Claudia Rengucci, Laura Capelli, Elisa Chiadini, Daniele Calistri, Chiara Bennati, Paola Cravero, Francesco Limarzi, Sofia Nosseir, Riccardo Panzacchi, Mirca Valli, Paola Ulivi, Giulio Rossi
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 10019-10032 (2023)
(1) Background: BRAF mutations affect 4–5% of lung adenocarcinomas. This study aimed to analyze the clinicopathological features of lung carcinomas with BRAF mutations, focusing on V600E vs. non-V600E and the presence of co-mutations. (2) Methods:
Externí odkaz:
https://doaj.org/article/a24728bdb9794b049738a5d9ecacc992
Autor:
Manlio Monti, Giovanni Marconi, Andrea Ambrosini-Spaltro, Chiara Gallio, Virginia Ghini, Luca Esposito, Stefano Antonini, Daniela Montanari, Giovanni Luca Frassineti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition characterized by uncontrolled activation of the immune system. HLH is a reactive mononuclear phagocytic response that occurs in association with a constellation of cond
Externí odkaz:
https://doaj.org/article/8d586ae4d3864deaad0359371b7d6d3e
Autor:
Andrea Ambrosini-Spaltro, Francesco Di Donato, Luca Saragoni, Gábor Cserni, Emad Rakha, Maria Pia Foschini
Publikováno v:
Cancers, Vol 15, Iss 11, p 3007 (2023)
(1) Background: The prognostic factors of microinvasive (≤1 mm) breast carcinoma are not completely clear. The aim of this study was to perform a systematic review and meta-analysis to clarify these factors. (2) Methods: The Preferred Reporting Ite
Externí odkaz:
https://doaj.org/article/8e51b429493649be8b9a16d80ced2910
Autor:
Lina Zuccatosta, Tommaso Bizzarro, Giulio Rossi, Graziana Gallo, Stefano Gasparini, Andrea Ambrosini-Spaltro
Publikováno v:
Diagnostics, Vol 13, Iss 2, p 249 (2023)
(1) Background. In the differential diagnosis between sarcomatoid carcinoma (SC) and sarcomatoid mesothelioma (SM), we aimed to investigate the role of Claudin-4 and BAP1, a panel recently used to distinguish conventional carcinoma from epithelioid m
Externí odkaz:
https://doaj.org/article/de78fb4661834a7d9d8e2488b8507e84
Autor:
Stefania, Caramaschi, Angela, Bertani, Stefania, Cerri, Antonio, Colecchia, Andrea, Ambrosini-Spaltro, Gianrocco, Manco, Tiziana, Salviato, Luca, Reggiani Bonetti
Publikováno v:
In Annals of Diagnostic Pathology February 2023 62
Autor:
Andrea Ambrosini-Spaltro, Francesco Limarzi, Michele Gaudio, Sebastiano Calpona, Giuseppe Meccariello
Publikováno v:
Virchows Archiv. 481:93-99
Immune checkpoint inhibitors have recently been approved for the treatment of advanced head and neck squamous cell carcinoma (HNSCC). The determination of PD-L1 using the combined positive score (CPS) is of utmost importance in the selection of patie
Autor:
Stefania Caramaschi, Angela Bertani, Stefania Cerri, Antonio Colecchia, Andrea Ambrosini-Spaltro, Gianrocco Manco, Tiziana Salviato, Luca Reggiani Bonetti
Publikováno v:
Annals of Diagnostic Pathology. 64:152131
Autor:
Andrea Ambrosini-Spaltro, Anna Farnedi, Daniele Calistri, Claudia Rengucci, Giovanna Prisinzano, Elisa Chiadini, Laura Capelli, Davide Angeli, Chiara Bennati, Mirca Valli, Giovanni De Luca, Dora Caruso, Paola Ulivi, Giulio Rossi
Publikováno v:
Human pathology. 123
Next-generation sequencing (NGS) is becoming a new gold standard for determining molecular predictive biomarkers. This study aimed to evaluate the reliability of NGS in detecting gene fusions, focusing on comparing gene fusions with known and unknown
Autor:
Luca Saragoni, Edgardo Contato, Elena Pacella, Luca Morelli, Elda Feyles, Mattia Barbareschi, Gerardo Ferrara, Maria Paola Mariani, Ezio Venturino, Ludovica De Vincentiis, Andrea Ambrosini-Spaltro, Enrico Orvieto, Valentina Bertolini, Filippo Crivelli
Publikováno v:
American Journal of Clinical Pathology
Objectives We performed data collection concerning the coronavirus disease 2019 (COVID-19) pandemic-related delay in the diagnosis of cancers to individuate proper corrective procedures. Methods A comparison was made among the number of first patholo
Autor:
Angelo Delmonte, Federica Pieri, Venerino Poletti, Andrea Ambrosini-Spaltro, Claudia Ravaglia, Alessandra Dubini
Publikováno v:
Ambrosini-Spaltro, A, Dubini, A, Pieri, F, Ravaglia, C, Delmonte, A & Poletti, V 2021, ' PD-L1 expression in NSCLC : Role of cell blocks and concordance between samples ', Diagnostic Cytopathology, vol. 49, no. 2, pp. 303-310 . https://doi.org/10.1002/dc.24646
Background: PD-L1 immunohistochemistry is currently performed in patients with advanced non-small cell lung carcinoma (NSCLC) to identify responders to immune checkpoint inhibitors. Cell blocks from fine needle aspiration of NSCLC are frequently used